March 13, 2020

Biopharma developing Corona vaccine relies on Single Use Support technologies

Amid the spread of the novel coronavirus COVID-19, the biopharmaceutical industry worldwide is researching vaccines against the virus.
The Austrian company Single Use Support GmbH is also involved: a US-biotech company trusts in the single-use technologies of single use support during the clinical phases of the vaccine development against SARS-CoV-2 virus. The products used for this, RoSS and RoSS.KSET, ensure safe transport and efficient storage of the high-quality active ingredients.

Medical substances are filled (single-use filtration system) into customary single-use bags for transport. The robust products from Single Use Support provide all-round protection for liquid medicine in the bag during filling, freezing, thawing, storing and transporting. In addition, the products from Single Use Support can be used in the logistics of active pharmaceutical ingredients for cell and gene therapies, personalized medicine, clinical trials and for commercialized vaccines.

Photos may be used free of charge if the copyright ©Single Use Support is given.


Michael Eder

Business Development / Marketing Manager